Hollencrest Capital Management Reduces Position in Colony NorthStar Inc (CLNS)
Hollencrest Capital Management lessened its stake in shares of Colony NorthStar Inc (NYSE:CLNS) by 7.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 85,125 shares of the real estate investment trust’s stock after selling 6,397 shares during the period. Hollencrest Capital Management’s holdings in Colony NorthStar were worth $971,000 at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. Syntal Capital Partners LLC acquired a new position in shares of Colony NorthStar during the 4th quarter valued at $259,000. Schroder Investment Management Group acquired a new position in shares of Colony NorthStar during the 2nd quarter valued at $392,000. Starfire Investment Advisers Inc. acquired a new position in shares of Colony NorthStar during the 4th quarter valued at $385,000. Wasatch Advisors Inc. lifted its position in shares of Colony NorthStar by 58.7% during the 4th quarter. Wasatch Advisors Inc. now owns 56,410 shares of the real estate investment trust’s stock valued at $644,000 after acquiring an additional 20,870 shares during the period. Finally, K2 Principal Fund L.P. lifted its position in shares of Colony NorthStar by 18.5% during the 3rd quarter. K2 Principal Fund L.P. now owns 99,919 shares of the real estate investment trust’s stock valued at $1,255,000 after acquiring an additional 15,587 shares during the period. Institutional investors own 82.29% of the company’s stock.
Colony NorthStar Inc (CLNS) traded down $0.10 on Friday, reaching $10.14. 3,770,000 shares of the company’s stock traded hands, compared to its average volume of 4,050,000. The company has a debt-to-equity ratio of 0.95, a quick ratio of 4.64 and a current ratio of 4.64. Colony NorthStar Inc has a 1 year low of $10.10 and a 1 year high of $14.74. The firm has a market capitalization of $5,530.00, a P/E ratio of -253.50 and a beta of 1.46.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, January 15th. Shareholders of record on Friday, December 29th were issued a dividend of $0.27 per share. The ex-dividend date of this dividend was Thursday, December 28th. This represents a $1.08 annualized dividend and a yield of 10.65%. Colony NorthStar’s payout ratio is -2,700.00%.
In other Colony NorthStar news, insider Neale Redington sold 12,500 shares of the company’s stock in a transaction on Wednesday, December 20th. The shares were sold at an average price of $11.74, for a total transaction of $146,750.00. Following the transaction, the insider now owns 182,908 shares in the company, valued at $2,147,339.92. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Vice Chairman David T. Hamamoto sold 449,780 shares of the company’s stock in a transaction on Monday, December 18th. The stock was sold at an average price of $12.05, for a total transaction of $5,419,849.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 3,493,363 shares of company stock worth $42,260,703. Corporate insiders own 7.99% of the company’s stock.
CLNS has been the topic of a number of research reports. ValuEngine upgraded shares of Colony NorthStar from a “hold” rating to a “buy” rating in a research report on Wednesday, December 6th. Zacks Investment Research downgraded shares of Colony NorthStar from a “hold” rating to a “sell” rating in a research report on Wednesday, January 10th. B. Riley reiterated a “buy” rating on shares of Colony NorthStar in a research report on Wednesday, November 1st. JMP Securities upgraded shares of Colony NorthStar from a “market perform” rating to an “outperform” rating and set a $13.00 target price on the stock in a research report on Friday, January 5th. Finally, FBR & Co restated a “buy” rating and set a $15.00 price objective on shares of Colony NorthStar in a report on Tuesday, October 3rd. One analyst has rated the stock with a sell rating, five have issued a buy rating and one has issued a strong buy rating to the company. Colony NorthStar currently has a consensus rating of “Buy” and a consensus target price of $16.05.
TRADEMARK VIOLATION WARNING: “Hollencrest Capital Management Reduces Position in Colony NorthStar Inc (CLNS)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://www.thecerbatgem.com/2018/01/19/hollencrest-capital-management-reduces-position-in-colony-northstar-inc-clns.html.
Colony NorthStar Profile
Colony NorthStar, Inc is a diversified equity real estate investment trust (REIT). The Company combines a portfolio of real assets across the world, which are managed with a global real estate investment manager. The Company has property holdings in the healthcare, industrial and hospitality sectors, opportunistic equity and debt investments, and an embedded institutional and retail investment management business.
Want to see what other hedge funds are holding CLNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colony NorthStar Inc (NYSE:CLNS).
Receive News & Ratings for Colony NorthStar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colony NorthStar and related companies with MarketBeat.com's FREE daily email newsletter.